Ensysce Biosciences (ENSCW) Depreciation & Amortization (CF) (2020 - 2021)

Ensysce Biosciences (ENSCW) reported Depreciation & Amortization (CF) of $50.0 for Q3 2021, little changed year-over-year from $50.0 in Q3 2020, and little changed quarter-over-quarter from $50.0 in Q2 2021.

Ensysce Biosciences (ENSCW) Depreciation & Amortization (CF) (2020 - 2021) Analysis & Trends

Ensysce Biosciences (ENSCW) has 2 years of Depreciation & Amortization (CF) data on file, last reported at $50.0 in Q3 2021.

  • Depreciation & Amortization (CF) for Q3 2021 came in at $50.0, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2022 was $50.0 (down 75.37% YoY), and the FY2021 annual result was $151.0, down 24.88% from the prior year.
  • Depreciation & Amortization (CF) held at $50.0 in Q3 2021 per ENSCW's latest filing, from $50.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $52.0 in Q4 2020 and troughed at $50.0 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 429,663.65
10 Ensysce Biosciences - - - -

Historic Data

Download Data
DateValue
Sep 30, 2021 50.00
Sep 30, 2021 50.00
Jun 30, 2021 50.00
Jun 30, 2021 50.00
Mar 31, 2021 51.00
Mar 31, 2021 51.00
Dec 31, 2020 52.00
Dec 31, 2020 52.00
Sep 30, 2020 50.00
Sep 30, 2020 50.00
Jun 30, 2020 50.00
Jun 30, 2020 50.00